Long non-coding RNA Fer-1-like protein 4 suppresses oncogenesis and exhibits prognostic value by associating with miR-106a-5p in colon cancer

Cancer Science

Volumn 106, Issue 10, 2015, Pages 1323-1332

  Yue, Ben ^a   Sun, Bo ^a   Liu, Chenchen ^a   Zhao, Senlin ^a   Zhang, Dongyuan ^a   Yu, Fudong ^a   Yan, Dongwang ^a  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

Author keywords

Colon cancer; FER1L4; MiR 106a 5p; Prognosis; Tumor marker

Indexed keywords

FER 1 LIKE PROTEIN 4; LONG UNTRANSLATED RNA; MICRORNA; MICRORNA 106A 5P; UNCLASSIFIED DRUG; LONG NON-CODING RNA FER1L4, HUMAN; MIRN106 MICRORNA, HUMAN;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER TISSUE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DOWN REGULATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR INVASION; VERY ELDERLY; BLOOD; CELL MOTION; CELL TRANSFORMATION; COLON TUMOR; GENE EXPRESSION REGULATION; GENETICS; HCT 116 CELL LINE; METABOLISM; MIDDLE AGED; PATHOLOGY; TUMOR CELL LINE;

ADULT; AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HUMANS; LYMPHATIC METASTASIS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; RNA, LONG NONCODING;

EID: 84945151241     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12759     Document Type: Article

References (39)

1. Ferlay J, Shin HR, Bray F et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-917.
2. emal A, Siegel R, Xu J et al. Cancer statistics, 2010. CA: A Cancer J Clin 2010; 60: 277-300.
3. Wapinski O, Chang HY. Long noncoding RNAs and human disease. Trends Cell Biol 2011; 21: 354-61.
4. Clark MB, Johnston RL, Inostroza-Ponta M et al. Genome-wide analysis of long noncoding RNA stability. Genome Res 2012; 22: 885-98.
5. Rinn JL, Chang HY. Genome regulation by long noncoding RNAs. Annu Rev Biochem 2012; 81: 145-66.
6. Gibb EA, Brown CJ, Lam WL. The functional role of long non-coding RNA in human carcinomas. Mol Cancer 2011; 10: 38.
7. Mitra SA, Mitra AP, Triche TJ. A central role for long non-coding RNA in cancer. Front Genet 2012; 3: 17.
8. Khalil AM, Guttman M, Huarte M et al. Many human large intergenic noncoding RNAs associate with chromatin modifying complexes and affect gene expression. Proc Natl Acad Sci USA 2009; 106: 11667-72.
9. Guttman M, Rinn JL. Modular regulatory principles of large non-coding RNAs. Nature 2012; 482: 339-46.
10. Tang JY, Lee JC, Chang YT et al. Long noncoding RNAs-related diseases, cancers, and drugs. Sci World J 2013; 2013: 943539.
11. Shao Y, Chen H, Jiang X et al. Low expression of lncRNA-HmlincRNA717 in human gastric cancer and its clinical significances. Tumour Biol 2014; 35: 9591-5.
12. Li J, Chen Z, Tian L et al. LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma. Gut 2014; 63: 1700-10.
13. Ji P, Diederichs S, Wang W et al. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 2003; 22: 8031-41.
14. Gupta RA, Shah N, Wang KC et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010; 464: 1071-6.
15. Tsai MC, Spitale RC, Chang HY. Long intergenic noncoding RNAs: New links in cancer progression. Cancer Res 2011; 71: 3-7.
16. Xia T, Liao Q, Jiang X et al. Long noncoding RNA associated-competing endogenous RNAs in gastric cancer. Sci Rep 2014; 4: 6088.
17. Xu TP, Huang MD, Xia R et al. Decreased expression of the long non-coding RNA FENDRR is associated with poor prognosis in gastric cancer and FENDRR regulates gastric cancer cell metastasis by affecting fibronectin1 expression. J Hematol Oncol 2014; 7: 63.
18. Borel F, Konstantinova P, Jansen PL. Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma. J Hepatol 2012; 56: 1371-83.
19. Ma MZ, Chu BF, Zhang Y et al. Long non-coding RNA CCAT 1 promotes gallbladder cancer development via negative modulation of miRNA-218-5p. Cell Death Dis 2015; 6: e1583.
20. Yuan JH, Yang F, Wang F et al. A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell 2014; 25: 666-81.
21. Wu ZH, Wang XL, Tang HM et al. Long non-coding RNA HOTAIR is a powerful predictor of metastasis and poor prognosis and is associated with epithelial-mesenchymal transition in colon cancer. Oncol Rep 2014; 32: 395-402.
22. Liu Q, Huang J, Zhou N et al. LncRNA loc285194 is a p53-regulated tumor suppressor. Nucleic Acids Res 2013; 41: 4976-87.
23. Song H, Sun W, Ye G et al. Long non-coding RNA expression profile in human gastric cancer and its clinical significances. J Transl Med 2013; 11: 225.
24. Salmena L, Poliseno L, Tay Y et al. A ceRNA hypothesis: The Rosetta Stone of a hidden RNA language? Cell 2011; 146: 353-8.
25. Jalali S, Bhartiya D, Lalwani MK et al. Systematic transcriptome wide analysis of lncRNA-miRNA interactions. PLoS ONE 2013; 8: e53823.
26. Wang J, Liu X, Wu H et al. CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res 2010; 38: 5366-83.
27. Kallen AN, Zhou XB, Xu J et al. The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol Cell 2013; 52: 101-12.
28. Liu XH, Sun M, Nie FQ et al. Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer. Mol Cancer 2014; 13: 92.
29. Ye SB, Li ZL, Luo DH et al. Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma. Oncotarget 2014; 5: 5439-52.
30. Müller S, Nowak K. Exploring the miRNA-mRNA regulatory network in clear cell renal cell carcinomas by next-generation sequencing expression profiles. Biomed Res Int 2014; 2014: 948408.
31. Zhi F, Zhou G, Shao N et al. miR-106a-5p inhibits the proliferation and migration of astrocytoma cells and apoptosis by targeting FASTK. PLoS ONE 2013; 8: e72390.
32. Zhi F, Shao N, Wang R et al. Identification of 9 serum microRNAs as potential noninvasive biomarkers of human astrocytoma. Neuro Oncol 2015; 17: 383-91.
33. Foltran L, Maglio GD, Pella N et al. Prognostic role of KRAS, NRAS, BRAF and PIK3CA mutations in advanced colorectal cancer. Future Oncol 2015; 11: 629-40.
34. Jiang Y, Zhang C, Chen K et al. The clinical significance of DC-SIGN and DC-SIGNR, which are novel markers expressed in human colon cancer. PLoS ONE 2014; 9: e114748.
35. Han Y, Yang YN, Yuan HH et al. UCA1, a long non-coding RNA up-regulated in colorectal cancer influences cell proliferation, apoptosis and cell cycle distribution. Pathology 2014; 46: 396-401.
36. Liu Z, Shao Y, Shi H et al. Clinical significance of the low expression of FER1L4 in gastric cancer patients. Tumour Biol 2014; 35: 9613-7.
37. Aherne ST, Madden SF, Huqhes DJ et al. Circulating miRNAs miR-34a and miR-150 associated with colorectal cancer progression. BMC Cancer 2015; 15: 329.
38. Zhang L, Chen X, Su T et al. Circulating miR-499 are novel and sensitive biomarker of acute myocardial infarction. J Thorac Dis 2015; 7: 303-8.
39. Zhang YH, Xia LH, Jin JM et al. Expression level of miR-155 in peripheral blood. Asian Pac J Trop Med 2015; 8: 214-9.